A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Peripheral Biomarkers in Multiple Sclerosis Patients Treated with Interferon-Beta
Neuroimmunology [Working Title]
Multiple sclerosis is a relapsing and eventually progressive disorder of the central nervous system that continues to challenge researchers who try to understand the pathogenesis of the disease and prevent its progression. Interferon-beta is the most widely prescribed treatment for MS. Peripheral blood seems to mirror the immunological disturbances that underlie MS, which could represent the migration patterns between periphery and other tissues according to the clinical phase of the disease.doi:10.5772/intechopen.99006 fatcat:muqmsn2nx5dljnaym5uehglsr4